Human Papillomavirus Regulates HER3 Expression in Head and Neck Cancer: Implications for Targeted HER3 Therapy in HPV+ PatientsToni M. Brand, Jennifer R. Grandis, Daniel E. Johnson et al.|Clinical Cancer Research|2016Cited by 58
Cross-talk Signaling between HER3 and HPV16 E6 and E7 Mediates Resistance to PI3K Inhibitors in Head and Neck CancerToni M. Brand, Jennifer R. Grandis, Stefan Hartmann et al.|Cancer Research|2018Cited by 43
Molecular and Clinical Activity of CDX-3379, an Anti-ErbB3 Monoclonal Antibody, in Head and Neck Squamous Cell Carcinoma PatientsUmamaheswar Duvvuri, Julie E. Bauman, Jonathan George et al.|Clinical Cancer Research|2019Cited by 42
HER3 targeting potentiates growth suppressive effects of the PI3K inhibitor BYL719 in pre-clinical models of head and neck squamous cell carcinomaKara D. Meister, Umamaheswar Duvvuri, Neal R. Godse et al.|Scientific Reports|2019Cited by 19
Correction: Cross-talk Signaling between HER3 and HPV16 E6 and E7 Mediates Resistance to PI3K Inhibitors in Head and Neck CancerToni M. Brand, Jennifer R. Grandis, Stefan Hartmann et al.|Cancer Research|2022Cited by 5